Search Results

Biotech Bay

Pulse Biosciences Announces Collaboration with CardioNXT for nsPFA First-in-Human Atrial Fibrillation Study

Pulse Biosciences, Inc. today announced a collaboration with CardioNXT, to support Pulse Biosciences’ planned nsPFA cardiac catheter first-in-human study focused on the treatment of atrial fibrillation.

October 2, 2023

·

3 min read

BioMidwest

Field Medical and CardioNXT Collaborate to Deliver Novel Integration of Focal Pulsed Field Ablation And 3D Mapping & Navigation For Treatment of Cardiac Arrhythmias

Field Medical, Inc. and CardioNXT, Inc. announce a strategic collaboration to provide the first-of-its-kind, purpose built, focal pulsed field ablation therapy integrated seamlessly with 3D mapping & navigation.

December 13, 2022

·

2 min read

FDA

CardioNXT wins FDA nod for heart treatment delivery platform

CardioNXT announced today that it received marketing clearance from the U.S. Food and Drug Administration (FDA) for the platform technology comprised of the iMap 3D Navigation & Mapping System ™ , Activate Software ™ , Sensor Enabled Axis Patient Patches ™ , and MultiLink Sensor Enabled Catheter ™ .

August 18, 2021

·

2 min read

Drug Development

CardioNXT Announces Enrollment Completion of RADAR Clinical Trial

CardioNXT and AFTx, related privately-held medical device companies, jointly announced today that the Real-time electrogram Analysis for Drivers of Atrial fibRillation (RADAR) clinical trial has reached full enrollment with 65 treated patients.

June 6, 2018

·

1 min read

BioMidwest

Former Medtronic CEO Gets in on CardioNXT’s $2.1 Million Funding Round

June 2, 2017

·

2 min read

BioMidwest

CardioNXT Secures Additional $1.5MM Funding From Solas BioVentures To Drive Atrial Fibrillation Treatment Innovation

May 25, 2016

·

2 min read

Biotech Bay

Pulse Biosciences Announces Its Novel Nanosecond Pulsed Field Ablation System Will Be Highlighted at the 2023 AF Symposium

Pulse Biosciences, Inc. today announced its technology will be highlighted in a poster presentation at the 28th Annual International AF Symposium meeting in Boston February 2–4.

February 2, 2023

·

4 min read

Biotech Bay

Pulse Biosciences Announces First-in-Human Procedures with its Novel CellFX™ Nanosecond Pulsed Field Ablation (nsPFA™) Cardiac Catheter

Pulse Biosciences, Inc. today announced the completion of the first five procedures in its first-in-human feasibility study with its novel CellFX nsPFA cardiac catheter.

December 20, 2023

·

7 min read

BioMidwest

Colorado BioScience Association Recaps Growth Year For State’s Life Science Sector

December 16, 2016

·

7 min read